Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma
Status:
Withdrawn
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of the pilot portion of this study is to establish the safety and
tolerability of an extended treatment break period in patients who have undergone neoadjuvant
chemoradiotherapy as well as use of systemic therapy during this break.